Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis

Peng, K; Blais, JE; Pratt, NL; Guo, JJ; Hillen, JB; Stanford, T; Ward, M; Lai, ECC; Shin, JY; Tong, XN; Fan, M; Cheng, FWT; Wu, J; Yeung, WWY; Lau, CS; Leung, WK; Wong, ICK; Li, X

Li, X (通讯作者)，Univ Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Med, Hong Kong, Peoples R China.;Wong, ICK; Li, X (通讯作者)，Univ Hong Kong, Li Ka Shing Fac Med, Ctr Safe Medicat Practice & Res, Dept Pharmacol & Pharm, Hong Kong, Peoples R China.;Wong, ICK; Li, X (通讯作者)，Lab Data Discovery Hlth D24H, Hong Kong Sci Pk, Hong Kong, Peoples R China.;Wong, ICK (通讯作者)，Aston Univ, Aston Pharm Sch, Birmingham, England.

BIODRUGS, 2023; 37 (3): 409

Abstract

ObjectiveWe aimed to assess whether the introduction of the first infliximab biosimilar was associated with changes in overall infliximab consumption ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索